跳至主要内容
临床试验/NCT04392024
NCT04392024已完成不适用

Clinical Outcome of Extended-depth-of-focus Trifocal Intraocualr Lens (Triumf) Implantation

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2020年1月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
9
试验地点
1
主要终点
Uncorrected distant visual acuity

研究概览

简要总结

Clinical outcome of extended-depth-of-focus trifocal intraocualr lens (Triumf) implantation

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Adult at the age of 21 or older at the time of the pre-operative examination and willing to have surgery on their 2nd eye within 7-28 days of their 1st eye
  • •Age-related cataract
  • •A patient with preoperative corneal astigmatism from IOL Master less than 1 diopters
  • •A patient want presbyopia correction at the same time as cataract surgery
  • •A patient has the visual potential of 20/25 or better in each eye after cataract removal and IOL implantation
  • •Written informed consent to surgery and participation in the study

排除标准

  • •Those with other diseases that can affect capsule stability such as pseudoexoliation syndrome, glaucoma, traumatic cataract
  • •Pregnant woman and lactating woman
  • •A patient with history of ocular trauma or ocular surgery (Intraocular surgery, refractive surgery, ocular surface surgery) in either eye
  • •A patient with evidence of keratoconus or significant irregular astigmatism on pre-operative topography in either eye
  • •If expectations for presbyopia correction are too high
  • •Those who are not able to read and understand the informed consent (illiterate or foreigners)

研究组 & 干预措施

Triumf

Other

Subjects who have cataract surgery with Triumf IOL

干预措施: Triumf (Device)

结局指标

主要结局

Uncorrected distant visual acuity

时间窗: 3 months

Visual acuity at distant with bare eyes

Uncorrected near visual acuity

时间窗: 3 months

Visual acuity at near with bare eyes

次要结局

  • Contrast sensitivity(3 months)
  • Quality of Vision(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

tae-young chung

Professor

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验